Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boden, G.
Right arrow Articles by Barton, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boden, G.
Right arrow Articles by Barton, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 44, Issue 10 1239-1242, Copyright © 1995 by American Diabetes Association


ARTICLES

Effects of a 48-h fat infusion on insulin secretion and glucose utilization

G Boden, X Chen, J Rosner and M Barton
Division of Endocrinology and Metabolism, Temple University School of Medicine, Philadelphia, Pennsylvania, USA.

To determine the effects of prolonged elevation of plasma free fatty acids (FFAs) on insulin secretion, we infused Liposyn II (4.3 mumol.kg-1.min-1) plus heparin (0.4 U.kg-1.min-1) intravenously into six healthy volunteers for 48 h. Another six volunteers received saline infusions and served as control subjects. In all 12 subjects (11 men and 1 woman), plasma glucose was clamped at approximately 8.6 mmol/l. Liposyn/heparin infusion resulted in a 9.4-fold increase in plasma FFA concentration (from 132 to 1,237 mumol/l), a 46% increase in insulin secretion rates (from 241 to 352 pmol/min, P < 0.05) (determined by deconvolution of plasma C-peptide concentration), and a 30% decrease, during the initial 24 h, in the rate of glucose infusion needed to maintain hyperglycemia (from 55.5 to 39.1 mumol.kg-1.min-1, P < 0.02). This decrease disappeared during the second 24 h. In summary, we found that physiologically elevated plasma FFAs 1) potentiated glucose-stimulated insulin secretion for 48 h and 2) initially caused peripheral insulin resistance that disappeared during the 2nd day, probably as a result of elevated circulating insulin levels. We conclude that in healthy volunteers under hyperglycemic conditions, fat infusion produced insulin resistance that was compensated for after approximately 24 h by persistent hypersecretion of insulin.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
A. I. Oprescu, G. Bikopoulos, A. Naassan, E. M. Allister, C. Tang, E. Park, H. Uchino, G. F. Lewis, I. G. Fantus, M. Rozakis-Adcock, et al.
Free Fatty Acid Induced Reduction in Glucose-Stimulated Insulin Secretion: Evidence for a Role of Oxidative Stress In Vitro and In Vivo
Diabetes, December 1, 2007; 56(12): 2927 - 2937.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. P. Kim, K. J. Catalano, I. R. Hsu, J. D. Chiu, J. M. Richey, and R. N. Bergman
Nocturnal free fatty acids are uniquely elevated in the longitudinal development of diet-induced insulin resistance and hyperinsulinemia
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1590 - E1598.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. Cusi, S. Kashyap, A. Gastaldelli, M. Bajaj, and E. Cersosimo
Effects on insulin secretion and insulin action of a 48-h reduction of plasma free fatty acids with acipimox in nondiabetic subjects genetically predisposed to type 2 diabetes
Am J Physiol Endocrinol Metab, June 1, 2007; 292(6): E1775 - E1781.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. T. Goh, T. M. Mason, N. Gupta, A. So, T. K. T. Lam, L. Lam, G. F. Lewis, A. Mari, and A. Giacca
Lipid-induced beta-cell dysfunction in vivo in models of progressive beta-cell failure
Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E549 - E560.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Migrenne, C. Cruciani-Guglielmacci, L. Kang, R. Wang, C. Rouch, A.-L. Lefevre, A. Ktorza, V. H. Routh, B. E. Levin, and C. Magnan
Fatty Acid Signaling in the Hypothalamus and the Neural Control of Insulin Secretion
Diabetes, December 1, 2006; 55(Supplement_2): S139 - S144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
H. Yoshii, T. K. T. Lam, N. Gupta, T. Goh, C. A. Haber, H. Uchino, T. T. Y. Kim, V. Z. Chong, K. Shah, I. G. Fantus, et al.
Effects of portal free fatty acid elevation on insulin clearance and hepatic glucose flux
Am J Physiol Endocrinol Metab, June 1, 2006; 290(6): E1089 - E1097.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Camastra, M. Manco, A. Mari, S. Baldi, A. Gastaldelli, A. V. Greco, G. Mingrone, and E. Ferrannini
{beta}-Cell Function in Morbidly Obese Subjects During Free Living: Long-Term Effects of Weight Loss
Diabetes, August 1, 2005; 54(8): 2382 - 2389.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
Z. T. Bloomgarden
Second World Congress on the Insulin Resistance Syndrome: Mediators, pediatric insulin resistance, the polycystic ovary syndrome, and malignancy
Diabetes Care, July 1, 2005; 28(7): 1821 - 1830.
[Full Text] [PDF]


Home page
Diabetes CareHome page
G. Boden and M. Laakso
Lipids and Glucose in Type 2 Diabetes: What About the {beta}-Cell and the Mitochondria?: Response to Eldor and Raz
Diabetes Care, April 1, 2005; 28(4): 986 - 987.
[Full Text] [PDF]


Home page
Diabetes CareHome page
O. Wuesten, C. H. Balz, R. G. Bretzel, H.-U. Kloer, and P. D. Hardt
Effects of Oral Fat Load on Insulin Output and Glucose Tolerance in Healthy Control Subjects and Obese Patients Without Diabetes
Diabetes Care, February 1, 2005; 28(2): 360 - 365.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. S. Remedi, Joseph. C. Koster, K. Markova, S. Seino, T. Miki, B. L. Patton, M. L. McDaniel, and C. G. Nichols
Diet-Induced Glucose Intolerance in Mice With Decreased {beta}-Cell ATP-Sensitive K+ Channels
Diabetes, December 1, 2004; 53(12): 3159 - 3167.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
S. B. Haugaard, O. Andersen, H. Storgaard, F. Dela, J. J. Holst, J. Iversen, J. O. Nielsen, and S. Madsbad
Insulin secretion in lipodystrophic HIV-infected patients is associated with high levels of nonglucose secretagogues and insulin resistance of {beta}-cells
Am J Physiol Endocrinol Metab, October 1, 2004; 287(4): E677 - E685.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
G. Boden and M. Laakso
Lipids and Glucose in Type 2 Diabetes: What is the cause and effect?
Diabetes Care, September 1, 2004; 27(9): 2253 - 2259.
[Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
Z. Gao, X. Zhang, A. Zuberi, D. Hwang, M. J. Quon, M. Lefevre, and J. Ye
Inhibition of Insulin Sensitivity by Free Fatty Acids Requires Activation of Multiple Serine Kinases in 3T3-L1 Adipocytes
Mol. Endocrinol., August 1, 2004; 18(8): 2024 - 2034.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
D. R. Sessions, S. E. Reedy, M. M. Vick, B. A. Murphy, and B. P. Fitzgerald
Development of a model for inducing transient insulin resistance in the mare: Preliminary implications regarding the estrous cycle
J Anim Sci, August 1, 2004; 82(8): 2321 - 2328.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Lupi, S. Del Guerra, L. Marselli, M. Bugliani, U. Boggi, F. Mosca, P. Marchetti, and S. Del Prato
Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPAR{gamma}2 in the modulation of insulin secretion
Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E560 - E567.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. Storgaard, C. B. Jensen, M. Bjornholm, X. M. Song, S. Madsbad, J. R. Zierath, and A. A. Vaag
Dissociation between Fat-Induced in Vivo Insulin Resistance and Proximal Insulin Signaling in Skeletal Muscle in Men at Risk for Type 2 Diabetes
J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1301 - 1311.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. C. Moore, S. Satake, M. Lautz, S. A. Soleimanpour, D. W. Neal, M. Smith, and A. D. Cherrington
Nonesterified Fatty Acids and Hepatic Glucose Metabolism in the Conscious Dog
Diabetes, January 1, 2004; 53(1): 32 - 40.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
S. Kashyap, R. Belfort, A. Gastaldelli, T. Pratipanawatr, R. Berria, W. Pratipanawatr, M. Bajaj, L. Mandarino, R. DeFronzo, and K. Cusi
A Sustained Increase in Plasma Free Fatty Acids Impairs Insulin Secretion in Nondiabetic Subjects Genetically Predisposed to Develop Type 2 Diabetes
Diabetes, October 1, 2003; 52(10): 2461 - 2474.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Kim, M. Haluzik, Z. Asghar, D. Yau, J. W. Joseph, A. M. Fernandez, M. L. Reitman, S. Yakar, B. Stannard, L. Heron-Milhavet, et al.
Peroxisome Proliferator-Activated Receptor-{alpha} Agonist Treatment in a Transgenic Model of Type 2 Diabetes Reverses the Lipotoxic State and Improves Glucose Homeostasis
Diabetes, July 1, 2003; 52(7): 1770 - 1778.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. B. Jensen, H. Storgaard, J. J. Holst, F. Dela, S. Madsbad, and A. A. Vaag
Insulin Secretion and Cellular Glucose Metabolism after Prolonged Low-Grade Intralipid Infusion in Young Men
J. Clin. Endocrinol. Metab., June 1, 2003; 88(6): 2775 - 2783.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Stefan, M. Stumvoll, C. Bogardus, and P. A. Tataranni
Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT
Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1156 - E1161.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. Kuhlmann, C. Neumann-Haefelin, U. Belz, J. Kalisch, H.-P. Juretschke, M. Stein, E. Kleinschmidt, W. Kramer, and A. W. Herling
Intramyocellular Lipid and Insulin Resistance: A Longitudinal In Vivo 1H-Spectroscopic Study in Zucker Diabetic Fatty Rats
Diabetes, January 1, 2003; 52(1): 138 - 144.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. Qvigstad, I. L. Mostad, K. S. Bjerve, and V. E. Grill
Acute lowering of circulating fatty acids improves insulin secretion in a subset of type 2 diabetes subjects
Am J Physiol Endocrinol Metab, January 1, 2003; 284(1): E129 - E137.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J.-M. Ye, G. Frangioudakis, M. A. Iglesias, S. M. Furler, B. Ellis, N. Dzamko, G. J. Cooney, and E. W. Kraegen
Prior Thiazolidinedione Treatment Preserves Insulin Sensitivity in Normal Rats during Acute Fatty Acid Elevation: Role of the Liver
Endocrinology, December 1, 2002; 143(12): 4527 - 4535.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. W. Van Citters, M. Kabir, S. P. Kim, S. D. Mittelman, M. K. Dea, P. L. Brubaker, and R. N. Bergman
Elevated Glucagon-Like Peptide-1-(7-36)-Amide, but Not Glucose, Associated with Hyperinsulinemic Compensation for Fat Feeding
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5191 - 5198.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. L. Dobbins, L. S. Szczepaniak, J. Myhill, Y. Tamura, H. Uchino, A. Giacca, and J. D. McGarry
The Composition of Dietary Fat Directly Influences Glucose-Stimulated Insulin Secretion in Rats
Diabetes, June 1, 2002; 51(6): 1825 - 1833.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Lupi, F. Dotta, L. Marselli, S. Del Guerra, M. Masini, C. Santangelo, G. Patane, U. Boggi, S. Piro, M. Anello, et al.
Prolonged Exposure to Free Fatty Acids Has Cytostatic and Pro-Apoptotic Effects on Human Pancreatic Islets: Evidence that {beta}-Cell Death Is Caspase Mediated, Partially Dependent on Ceramide Pathway, and Bcl-2 Regulated
Diabetes, May 1, 2002; 51(5): 1437 - 1442.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
G. F. Lewis, A. Carpentier, K. Adeli, and A. Giacca
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
Endocr. Rev., April 1, 2002; 23(2): 201 - 229.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Lupi, S. Del Guerra, V. Fierabracci, L. Marselli, M. Novelli, G. Patane, U. Boggi, F. Mosca, S. Piro, S. Del Prato, et al.
Lipotoxicity in Human Pancreatic Islets and the Protective Effect of Metformin
Diabetes, February 1, 2002; 51(90001): S134 - 137.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. N. Bergman, M. Ader, K. Huecking, and G. Van Citters
Accurate Assessment of {beta}-Cell Function: The Hyperbolic Correction
Diabetes, February 1, 2002; 51(90001): S212 - 220.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. D. McGarry
Banting Lecture 2001: Dysregulation of Fatty Acid Metabolism in the Etiology of Type 2 Diabetes
Diabetes, January 1, 2002; 51(1): 7 - 18.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Magnan, C. Cruciani, L. Clement, P. Adnot, M. Vincent, M. Kergoat, A. Girard, J.-L. Elghozi, G. Velho, N. Beressi, et al.
Glucose-Induced Insulin Hypersecretion in Lipid-Infused Healthy Subjects Is Associated with a Decrease in Plasma Norepinephrine Concentration and Urinary Excretion
J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4901 - 4907.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. E. Kahn
The Importance of {beta}-Cell Failure in the Development and Progression of Type 2 Diabetes
J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4047 - 4058.
[Full Text] [PDF]


Home page
J. Nutr.Home page
V. A. Zammit, I. J. Waterman, D. Topping, and G. McKay
Insulin Stimulation of Hepatic Triacylglycerol Secretion and the Etiology of Insulin Resistance
J. Nutr., August 1, 2001; 131(8): 2074 - 2077.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
N. Stefan, A. Fritsche, H. Häring, and M. Stumvoll
Effect of Experimental Elevation of Free Fatty Acids on Insulin Secretion and Insulin Sensitivity in Healthy Carriers of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor-{gamma}2 Gene
Diabetes, May 1, 2001; 50(5): 1143 - 1148.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. J. Kaiyala, R. L. Prigeon, S. E. Kahn, S. C. Woods, D. Porte Jr., and M. W. Schwartz
Reduced beta -cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding
Am J Physiol Endocrinol Metab, October 1, 1999; 277(4): E659 - E667.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Carpentier, S. D. Mittelman, R. N. Bergman, A. Giacca, and G. F. Lewis
Acute enhancement of insulin secretion by FFA in humans is lost with prolonged FFA elevation
Am J Physiol Endocrinol Metab, June 1, 1999; 276(6): E1055 - E1066.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. F. Horowitz, S. W. Coppack, D. Paramore, P. E. Cryer, G. Zhao, and S. Klein
Effect of short-term fasting on lipid kinetics in lean and obese women
Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E278 - E284.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. Sivan, C. J. Homko, P. G. Whittaker, E. A. Reece, X. Chen, and G. Boden
Free Fatty Acids and Insulin Resistance during Pregnancy
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2338 - 2342.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Ranheim, C. Dumke, K. L. Schueler, G. D. Cartee, and A. D. Attie
Interaction Between BTBR and C57BL/6J Genomes Produces an Insulin Resistance Syndrome in (BTBR x C57BL/6J) F1 Mice
Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3286 - 3293.
[Abstract] [Full Text]


Home page
The Diabetes EducatorHome page
M. J. Franz
Protein: Metabolism and Effect on Blood Glucose Levels
The Diabetes Educator, January 1, 1997; 23(6): 643 - 651.
[PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1995 by the American Diabetes Association.